GanT Maintained at Outperform
Oppenheimer maintains Outperform rating on Gain Therapeutics. No change to estimates.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Oppenheimer maintains Outperform rating on Gain Therapeutics. No change to estimates.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.